Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortization of GoodwillAmortization of GoodwillAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Acquisitions (2020 - 2025)

Health Catalyst posted quarterly Acquisitions of -$8000.0 for Q2 2025, down 100.04% year-on-year from $18.7 million in Q2 2024, and down 100.02% on a QoQ basis from $41.1 million in Q1 2025.

Health Catalyst (HCAT) has 6 years of Acquisitions data on file, last reported at -$8000.0 in Q2 2025.

  • For the quarter ending Q2 2025, Acquisitions fell 100.04% year-over-year to -$8000.0; the trailing twelve-month figure through Mar 2026 stood at -$8000.0 (down 100.01% YoY), and the FY2025 full-year result was $41.1 million, down 48.78% from the prior year.
  • Acquisitions for Q2 2025 stood at -$8000.0, down from $41.1 million in the prior quarter.
  • Across five years, Acquisitions topped out at $46.8 million in Q3 2021 and bottomed at -$8000.0 in Q2 2025.
  • The 5-year median for Acquisitions is $18.7 million (2024), against an average of $23.0 million.
  • The widest annual swing landed in 2024, when Acquisitions soared 122.86%; it then tumbled 100.04% in 2025.
  • A 5-year view of Acquisitions shows it stood at $46.8 million in 2021, then slumped by 80.03% to $9.3 million in 2022, then climbed by 22.01% to $11.4 million in 2023, then soared by 122.86% to $25.4 million in 2024, then plunged by 100.03% to -$8000.0 in 2025.
  • The last three Acquisitions figures came in at -$8000.0 (Q2 2025), $41.1 million (Q1 2025), and $25.4 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn -
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn 42.20 Mn
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn -
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn -
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn -
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn 2.04 Mn
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn -
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn -
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn -
10 Health Catalyst 98.36 Mn -10.46 Mn 35.46 Mn -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2025 -8,000.00
Mar 31, 2025 41.12 Mn
Dec 31, 2024 25.39 Mn
Sep 30, 2024 36.23 Mn
Jun 30, 2024 18.66 Mn
Dec 31, 2023 11.39 Mn
Jun 30, 2022 9.34 Mn
Mar 31, 2022 18.51 Mn
Sep 30, 2021 46.76 Mn
Dec 31, 2020 -814,000.00
Sep 30, 2020 87.22 Mn
Mar 31, 2020 15.25 Mn